Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) — Net Asset Momentum
Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) recorded a net asset momentum of -11.4% as of December 2024, with net assets of CN¥4.01 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Guangdong Zhongsheng Pharmaceutical Co L (002317) net assets for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Guangdong Zhongsheng Pharmaceutical Co Ltd Net Asset Momentum (2006–2024)
This chart tracks Guangdong Zhongsheng Pharmaceutical Co Ltd's year-over-year net asset growth across 19 annual reporting periods from 2006 to 2024. The most recent momentum reading is -11.4%, with net assets of CN¥4.01 Billion CNY as of December 2024. For live market cap and overall valuation, see 002317 company net worth.
Annual Net Asset History for Guangdong Zhongsheng Pharmaceutical Co Ltd (2006–2024)
The table below shows the complete annual net asset history for Guangdong Zhongsheng Pharmaceutical Co Ltd from 2006 to 2024, covering 19 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check Guangdong Zhongsheng Pharmaceutical Co L tangible book value ratio to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | CN¥4.01 Billion | CN¥5.55 Billion | CN¥1.54 Billion | ▼ -11.4% |
| 2023 | CN¥4.53 Billion | CN¥6.46 Billion | CN¥1.93 Billion | ▲ +18.6% |
| 2022 | CN¥3.82 Billion | CN¥5.78 Billion | CN¥1.96 Billion | ▲ +7.9% |
| 2021 | CN¥3.54 Billion | CN¥4.90 Billion | CN¥1.36 Billion | ▼ -2.4% |
| 2020 | CN¥3.63 Billion | CN¥4.78 Billion | CN¥1.15 Billion | ▼ -12.3% |
| 2019 | CN¥4.13 Billion | CN¥5.51 Billion | CN¥1.37 Billion | ▲ +4.6% |
| 2018 | CN¥3.95 Billion | CN¥5.24 Billion | CN¥1.29 Billion | ▲ +5.9% |
| 2017 | CN¥3.73 Billion | CN¥4.86 Billion | CN¥1.13 Billion | ▲ +8.9% |
| 2016 | CN¥3.42 Billion | CN¥4.23 Billion | CN¥801.23 Million | ▲ +62.3% |
| 2015 | CN¥2.11 Billion | CN¥3.33 Billion | CN¥1.22 Billion | ▲ +11.1% |
| 2014 | CN¥1.90 Billion | CN¥2.31 Billion | CN¥407.63 Million | ▲ +8.9% |
| 2013 | CN¥1.74 Billion | CN¥1.98 Billion | CN¥238.04 Million | ▲ +9.8% |
| 2012 | CN¥1.59 Billion | CN¥1.74 Billion | CN¥150.41 Million | ▲ +7.4% |
| 2011 | CN¥1.48 Billion | CN¥1.57 Billion | CN¥92.54 Million | ▲ +6.5% |
| 2010 | CN¥1.39 Billion | CN¥1.48 Billion | CN¥95.53 Million | ▲ +7.1% |
| 2009 | CN¥1.30 Billion | CN¥1.40 Billion | CN¥108.46 Million | ▲ +651.3% |
| 2008 | CN¥172.40 Million | CN¥314.92 Million | CN¥142.53 Million | ▲ +32.0% |
| 2007 | CN¥130.56 Million | CN¥297.74 Million | CN¥167.17 Million | ▼ -5.9% |
| 2006 | CN¥138.72 Million | CN¥291.65 Million | CN¥152.93 Million | — |